Spotlight Innovation launches new homeopathic topical analgesic solution

URBANDALE, Iowa — Spotlight Innovation on Monday announced that its subsidiary Caretta Therapeutics' new over-the-counter chronic pain relief product, Venodol roll-on, is now available for pre-order in the U.S. on the company's web site.



"We created Venodol to fill a need for a non-opioid alternative for the treatment of chronic pain," stated John Krohn, Spotlight Innovation president and CEO. "Chronic pain has a negative impact on the quality-of-life of millions of Americans, and we are proud to offer Venodol as an alternative to opioid analgesics."



Venodol roll-on is a topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation, including joint pain, tendinitis, arthritis (excluding osteoarthritis) and body aches. In the coming months Caretta Therapeutics plans to introduce additional Venodol product formats and to expand distribution to mass merchandise retailers. Venodol pre-orders are expected to ship on or before Aug. 21.



Venodol topical is a homeopathic analgesic that is scent-free, the company stated.